melanotan ii developed by which company (“Tan Jabs”): Why They're Not Worth The Risk Melanotan 2 - Oath Research
Description
Not sure whether MOTS-c, NAD+, or both fits your protocol
(PubMed) Abramovici A, Gandley RE, Clifton RG, et al
The key factor undermining the diagnosis and treatment efficacy of ME/CFS is the failure to identify the cause of this disease
178 RoeAJZhangSBhadeliaRAJohnsonEJLichtensteinAHRogersGTet al
